Unehäired kliinilised uuringud osariigis Florida
6 uuringut haiguse Unehäired jaoks otsivad osalejaid osariigis Florida.
Linnad osariigis Florida
Ametlik uuringutekst (inglise keeles)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- ja veel 5
VärbamineFaas 2/3
Vanused 18–70 · Kõik sood · Uuendatud 2. okt 2026 · NCT07598708A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07823608A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 3. sept 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Maimi
- Alkermes Investigational Site, Winter Park
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 3. sept 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 3. sept 2026 · NCT07540897A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
VärbamineFaas 2/3
Vanused 18–70 · Kõik sood · Uuendatud 7. aug 2026 · NCT06767683Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.